Still, CDC officials say virus appears related to strain seen in dairy cows
Latest
One negative trial in the phase III PROMIS program blamed squarely on the COVID-19 pandemic
Meta-analysis suggested lower stroke risk, but more definitive trial is not expected until 2032
However, full two-dose vaccine series likely needed to curtail mpox resurgence, researchers say
More Medical News
Plans will be barred from using more restrictive prior authorization rules for mental health care
Where medicine is all fun and games
Most Read
Perspectives
名媛直播
Featured
Members skeptical of verification process, concerned about patient safety
Even if ketamine isn't as addictive as opioids, widespread use can still pose problems
At least seven kids have died while playing football so far this year
Weekly News Quiz
You passed medical training, now see if you can pass our weekly quiz
Multi-step, condition-based, and doctor-reviewed resource library for physicians and their patients.See All Medical Journeys >
Meeting Coverage
More From 名媛直播
See the breakdown of this physician's weekly budget, from eating out to sailing lessons
The Republican nominee has shifted stances, even as abortion remains a top election issue
Healthcare social media content gathered by 名媛直播 staff
Health news and commentary gathered by 名媛直播 staff
Incidence almost identical to that with standard cancer treatment in randomized trials
"We should be cautious about using drugs off-label," investigator says
Attempts to recover organs from live donors "absolutely terrifying," House member says
Signal has generally trailed off, but more sensitive method showed virus lingering in Texas
Can treatment be scaled for implementation in the real world?
Relationship was mediated by comorbid dyslipidemia
A plastic surgeon weighs in on high-definition liposuction
Objective response rate was 55% with 12-mg/kg ifinatamab deruxtecan
Secondary analysis of trial data consistent with observational studies
Podcasts
Also in TTHealthWatch: beta-blockers after MI
名媛直播 reporters offer further insights into these recently covered topics
A discussion with the former CEO of the Bill & Melinda Gates Foundation
Three healthcare professionals describe when they were gaslit by their peers
From the Advisory Board
Team USA's chief medical officer also discusses what he learned in Paris to prepare for next time
This newly approved testing modality brings challenges and opportunities
Just because something is legal doesn't mean it's ethical
Unequal access threatens to worsen disparities
The potential benefits of CAR T-cell therapies still far outweigh the risks